A citation-based method for searching scientific literature

Praveen F Cherukuri, Valerie Maduro, Karin V Fuentes-Fajardo, Kevin Lam, David R Adams, Cynthia J Tifft, James C Mullikin, William A Gahl, Cornelius F Boerkoel. BMC Genomics 2015
Times Cited: 3







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.
Aaron McKenna, Matthew Hanna, Eric Banks, Andrey Sivachenko, Kristian Cibulskis, Andrew Kernytsky, Kiran Garimella, David Altshuler, Stacey Gabriel, Mark Daly,[...]. Genome Res 2010
66

A framework for variation discovery and genotyping using next-generation DNA sequencing data.
Mark A DePristo, Eric Banks, Ryan Poplin, Kiran V Garimella, Jared R Maguire, Christopher Hartl, Anthony A Philippakis, Guillermo del Angel, Manuel A Rivas, Matt Hanna,[...]. Nat Genet 2011
66

The germline variants in DNA repair genes in pediatric medulloblastoma: a challenge for current therapeutic strategies.
Joanna Trubicka, Tomasz Żemojtel, Jochen Hecht, Katarzyna Falana, Dorota Piekutowska-Abramczuk, Rafał Płoski, Marta Perek-Polnik, Monika Drogosiewicz, Wiesława Grajkowska, Elżbieta Ciara,[...]. BMC Cancer 2017
5
33

PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics.
Maria Currás-Freixes, Elena Piñeiro-Yañez, Cristina Montero-Conde, María Apellániz-Ruiz, Bruna Calsina, Veronika Mancikova, Laura Remacha, Susan Richter, Tonino Ercolino, Natalie Rogowski-Lehmann,[...]. J Mol Diagn 2017
36
33

A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
Eliezer M Van Allen, Dan Robinson, Colm Morrissey, Colin Pritchard, Alma Imamovic, Scott Carter, Mara Rosenberg, Aaron McKenna, Yi-Mi Wu, Xuhong Cao,[...]. Oncotarget 2016
13
33

Comparison of cell stabilizing blood collection tubes for circulating plasma tumor DNA.
Patricia Valda Toro, Bracha Erlanger, Julia A Beaver, Rory L Cochran, Dustin A VanDenBerg, Elizabeth Yakim, Karen Cravero, David Chu, Daniel J Zabransky, Hong Yuen Wong,[...]. Clin Biochem 2015
62
33

Germline Mutations in Predisposition Genes in Pediatric Cancer.
Jinghui Zhang, Michael F Walsh, Gang Wu, Michael N Edmonson, Tanja A Gruber, John Easton, Dale Hedges, Xiaotu Ma, Xin Zhou, Donald A Yergeau,[...]. N Engl J Med 2015
494
33

Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
Adrian G Sacher, Cloud Paweletz, Suzanne E Dahlberg, Ryan S Alden, Allison O'Connell, Nora Feeney, Stacy L Mach, Pasi A Jänne, Geoffrey R Oxnard. JAMA Oncol 2016
354
33

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.
Jeanne Tie, Yuxuan Wang, Cristian Tomasetti, Lu Li, Simeon Springer, Isaac Kinde, Natalie Silliman, Mark Tacey, Hui-Li Wong, Michael Christie,[...]. Sci Transl Med 2016
549
33

Detection of circulating tumor DNA in early- and late-stage human malignancies.
Chetan Bettegowda, Mark Sausen, Rebecca J Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R Bartlett, Hao Wang, Brandon Luber, Rhoda M Alani,[...]. Sci Transl Med 2014
33

Genomic EWSR1 Fusion Sequence as Highly Sensitive and Dynamic Plasma Tumor Marker in Ewing Sarcoma.
Manuela Krumbholz, Julia Hellberg, Benedikt Steif, Tobias Bäuerle, Clarissa Gillmann, Torsten Fritscher, Abbas Agaimy, Benjamin Frey, Joerg Juengert, Eva Wardelmann,[...]. Clin Cancer Res 2016
42
33

Analytical validation of whole exome and whole genome sequencing for clinical applications.
Michael D Linderman, Tracy Brandt, Lisa Edelmann, Omar Jabado, Yumi Kasai, Ruth Kornreich, Milind Mahajan, Hardik Shah, Andrew Kasarskis, Eric E Schadt. BMC Med Genomics 2014
65
33

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
269
33

A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor.
Samantha Gadd, Vicki Huff, Amy L Walz, Ariadne H A G Ooms, Amy E Armstrong, Daniela S Gerhard, Malcolm A Smith, Jaime M Guidry Auvil, Daoud Meerzaman, Qing-Rong Chen,[...]. Nat Genet 2017
123
33

Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma.
Elin S Gray, Helen Rizos, Anna L Reid, Suzanah C Boyd, Michelle R Pereira, Johnny Lo, Varsha Tembe, James Freeman, Jenny H J Lee, Richard A Scolyer,[...]. Oncotarget 2015
193
33

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
Jacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, Mohammad S Esfahani, Aaron M Newman, Henry J Haringsma, David M Kurtz, Henning Stehr, Florian Scherer, Chris A Karlovich,[...]. Nat Commun 2016
361
33

Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
Victoria M Pratt, Robin E Everts, Praful Aggarwal, Brittany N Beyer, Ulrich Broeckel, Ruth Epstein-Baak, Paul Hujsak, Ruth Kornreich, Jun Liao, Rachel Lorier,[...]. J Mol Diagn 2016
57
33

Efficient Detection of BRAF Mutation in Plasma of Patients after Long-term Storage of Blood in Cell-Free DNA Blood Collection Tubes.
Marc G Denis, Anne-Chantal Knol, Sandrine Théoleyre, Audrey Vallée, Brigitte Dréno. Clin Chem 2015
20
33

Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
Cassie N Kline, Nancy M Joseph, James P Grenert, Jessica van Ziffle, Eric Talevich, Courtney Onodera, Mariam Aboian, Soonmee Cha, David R Raleigh, Steve Braunstein,[...]. Neuro Oncol 2017
115
33

Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor.
William McLaren, Bethan Pritchard, Daniel Rios, Yuan Chen, Paul Flicek, Fiona Cunningham. Bioinformatics 2010
33

Comparison of three targeted enrichment strategies on the SOLiD sequencing platform.
Dale J Hedges, Toumy Guettouche, Shan Yang, Guney Bademci, Ashley Diaz, Ashley Andersen, William F Hulme, Sara Linker, Arpit Mehta, Yvonne J K Edwards,[...]. PLoS One 2011
50
33

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.
Isaac Garcia-Murillas, Gaia Schiavon, Britta Weigelt, Charlotte Ng, Sarah Hrebien, Rosalind J Cutts, Maggie Cheang, Peter Osin, Ashutosh Nerurkar, Iwanka Kozarewa,[...]. Sci Transl Med 2015
593
33

Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma.
Mathieu Chicard, Sandrine Boyault, Leo Colmet Daage, Wilfrid Richer, David Gentien, Gaelle Pierron, Eve Lapouble, Angela Bellini, Nathalie Clement, Isabelle Iacono,[...]. Clin Cancer Res 2016
49
33


A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial.
Masahiko Yanagita, Amanda J Redig, Cloud P Paweletz, Suzanne E Dahlberg, Allison O'Connell, Nora Feeney, Myriam Taibi, David Boucher, Geoffrey R Oxnard, Bruce E Johnson,[...]. Clin Cancer Res 2016
76
33

Genetic profiling of tumours using both circulating free DNA and circulating tumour cells isolated from the same preserved whole blood sample.
Dominic G Rothwell, Nigel Smith, Daniel Morris, Hui Sun Leong, Yaoyong Li, Antoine Hollebecque, Mahmood Ayub, Louise Carter, Jenny Antonello, Lynsey Franklin,[...]. Mol Oncol 2016
58
33

Analysis of circulating tumor DNA to monitor metastatic breast cancer.
Sarah-Jane Dawson, Dana W Y Tsui, Muhammed Murtaza, Heather Biggs, Oscar M Rueda, Suet-Feung Chin, Mark J Dunning, Davina Gale, Tim Forshew, Betania Mahler-Araujo,[...]. N Engl J Med 2013
33

Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma.
Kristina Warton, Vita Lin, Tina Navin, Nicola J Armstrong, Warren Kaplan, Kevin Ying, Brian Gloss, Helena Mangs, Shalima S Nair, Neville F Hacker,[...]. BMC Genomics 2014
41
33

ACMG clinical laboratory standards for next-generation sequencing.
Heidi L Rehm, Sherri J Bale, Pinar Bayrak-Toydemir, Jonathan S Berg, Kerry K Brown, Joshua L Deignan, Michael J Friez, Birgit H Funke, Madhuri R Hegde, Elaine Lyon. Genet Med 2013
526
33

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
Kristian Cibulskis, Michael S Lawrence, Scott L Carter, Andrey Sivachenko, David Jaffe, Carrie Sougnez, Stacey Gabriel, Matthew Meyerson, Eric S Lander, Gad Getz. Nat Biotechnol 2013
33

Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors.
Sho Kurihara, Yuka Ueda, Yoshiyuki Onitake, Taijiro Sueda, Emi Ohta, Nagisa Morihara, Shoko Hirano, Fumiko Irisuna, Eiso Hiyama. J Pediatr Surg 2015
29
33

Targeted enrichment of genomic DNA regions for next-generation sequencing.
Florian Mertes, Abdou Elsharawy, Sascha Sauer, Joop M L M van Helvoort, P J van der Zaag, Andre Franke, Mats Nilsson, Hans Lehrach, Anthony J Brookes. Brief Funct Genomics 2011
134
33

Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA.
Masanori Hayashi, David Chu, Christian F Meyer, Nicolas J Llosa, Gregory McCarty, Carol D Morris, Adam S Levin, Jean-Paul Wolinsky, Catherine M Albert, Diana A Steppan,[...]. Cancer 2016
36
33

Structural model of the OPA1 GTPase domain may explain the molecular consequences of a novel mutation in a family with autosomal dominant optic atrophy.
Sharareh Dadgar, Olivier Hagens, Seyed Razi Dadgar, Ehsan Nobakht Haghighi, Simone Schimpf, Bernd Wissinger, Masoud Garshasbi. Exp Eye Res 2006
5
33

Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.
C Delettre, G Lenaers, J M Griffoin, N Gigarel, C Lorenzo, P Belenguer, L Pelloquin, J Grosgeorge, C Turc-Carel, E Perret,[...]. Nat Genet 2000
33

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.
Kai Wang, Mingyao Li, Hakon Hakonarson. Nucleic Acids Res 2010
33

Visual acuities "hand motion" and "counting fingers" can be quantified with the freiburg visual acuity test.
Kilian Schulze-Bonsel, Nicolas Feltgen, Hermann Burau, Lutz Hansen, Michael Bach. Invest Ophthalmol Vis Sci 2006
426
33

Dominant optic atrophy.
Guy Lenaers, Christian Hamel, Cécile Delettre, Patrizia Amati-Bonneau, Vincent Procaccio, Dominique Bonneau, Pascal Reynier, Dan Milea. Orphanet J Rare Dis 2012
121
33

Cigarette toxicity triggers Leber's hereditary optic neuropathy by affecting mtDNA copy number, oxidative phosphorylation and ROS detoxification pathways.
L Giordano, S Deceglie, P d'Adamo, M L Valentino, C La Morgia, F Fracasso, M Roberti, M Cappellari, G Petrosillo, S Ciaravolo,[...]. Cell Death Dis 2015
59
33


OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance.
U E Pesch, B Leo-Kottler, S Mayer, B Jurklies, U Kellner, E Apfelstedt-Sylla, E Zrenner, C Alexander, B Wissinger. Hum Mol Genet 2001
142
33

Loss of functional OPA1 unbalances redox state: implications in dominant optic atrophy pathogenesis.
Aurélie M C Millet, Ambre M Bertholet, Marlène Daloyau, Pascal Reynier, Anne Galinier, Anne Devin, Bernd Wissinguer, Pascale Belenguer, Noélie Davezac. Ann Clin Transl Neurol 2016
20
33

Toxic optic neuropathies: an updated review.
Andrzej Grzybowski, Magdalena Zülsdorff, Helmut Wilhelm, Felix Tonagel. Acta Ophthalmol 2015
60
33

Prevalence of Mitochondrial ND4 Mutations in 1281 Han Chinese Subjects With Leber's Hereditary Optic Neuropathy.
Pingping Jiang, Min Liang, Juanjuan Zhang, Yinglong Gao, Zheyun He, Han Yu, Fuxin Zhao, Yanchun Ji, Xiaoling Liu, Minglian Zhang,[...]. Invest Ophthalmol Vis Sci 2015
33
33

ROMO1 is an essential redox-dependent regulator of mitochondrial dynamics.
Matthew Norton, Andy Cheuk-Him Ng, Stephen Baird, Ariane Dumoulin, Timothy Shutt, Nancy Mah, Miguel A Andrade-Navarro, Heidi M McBride, Robert A Screaton. Sci Signal 2014
68
33

Mutations in DNM1L, as in OPA1, result in dominant optic atrophy despite opposite effects on mitochondrial fusion and fission.
Sylvie Gerber, Majida Charif, Arnaud Chevrollier, Tanguy Chaumette, Claire Angebault, Mariame Selma Kane, Aurélien Paris, Jennifer Alban, Mélanie Quiles, Cécile Delettre,[...]. Brain 2017
59
33

OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract.
P Reynier, P Amati-Bonneau, C Verny, A Olichon, G Simard, A Guichet, C Bonnemains, F Malecaze, M C Malinge, J B Pelletier,[...]. J Med Genet 2004
107
33

Analysis of candidate genes for macular telangiectasia type 2.
Nancy L Parmalee, Carl Schubert, Joanna E Merriam, Kaija Allikmets, Alan C Bird, Mark C Gillies, Tunde Peto, Maria Figueroa, Martin Friedlander, Marcus Fruttiger,[...]. Mol Vis 2010
17
33

ROS as Regulators of Mitochondrial Dynamics in Neurons.
Carolina Cid-Castro, Diego Rolando Hernández-Espinosa, Julio Morán. Cell Mol Neurobiol 2018
39
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.